title: Is early, deep free light chain response really an adverse prognostic factor?
authors.forename: Angela
authors.initials: A
authors.lastname: Dispenzieri
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood / Q000652:urine; D015331:Cohort Studies; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000097:blood* / Q000652:urine; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy / Q000276:immunology; D011237:Predictive Value of Tests; D011379:Prognosis; D012016:Reference Values; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D015415:Biomarkers; D007147:Immunoglobulin Light Chains